Tyche Wealth Partners LLC Sellas Life Sciences Group, Inc. Transaction History
Tyche Wealth Partners LLC
- $570 Billion
- Q3 2025
A detailed history of Tyche Wealth Partners LLC transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Tyche Wealth Partners LLC holds 37,500 shares of SLS stock, worth $53,625. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37,500Holding current value
$53,625% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding SLS
# of Institutions
102Shares Held
28.9MCall Options Held
3.77MPut Options Held
93.3K-
Vanguard Group Inc Valley Forge, PA6.84MShares$9.78 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX6.03MShares$8.63 Million1.59% of portfolio
-
Marshall Wace, LLP London, X02.36MShares$3.37 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.26MShares$3.24 Million0.0% of portfolio
-
State Street Corp Boston, MA1.36MShares$1.95 Million0.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $29.4M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...